+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Precision Cancer Therapeutics, 2022 - Product Thumbnail Image

Precision Cancer Therapeutics, 2022

  • Report
  • November 2022
  • 154 Pages
  • Global
From
Phosphodiesterase V Inhibitor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Phosphodiesterase V Inhibitor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • August 2024
  • 91 Pages
  • Global
From
Remdesivir Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Remdesivir Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • January 2024
  • 150 Pages
  • Global
From
Asia Pacific Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

Asia Pacific Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 111 Pages
  • Asia Pacific
From
LAMEA Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

LAMEA Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 111 Pages
  • Middle East, Africa
From
Europe Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

Europe Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 110 Pages
  • Europe
From
North America Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Thumbnail Image

North America Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • April 2023
  • 100 Pages
  • North America
From
Capsid Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Capsid Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
MCL1 Protein Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

MCL1 Protein Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Porphyria - Pipeline Insight, 2025 - Product Thumbnail Image

Porphyria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
Asia Pacific (APAC) Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Asia Pacific (APAC) Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • October 2022
  • 82 Pages
  • Asia Pacific
From
Immunotherapy Drugs Market 2024-2028 - Product Thumbnail Image

Immunotherapy Drugs Market 2024-2028

  • Report
  • November 2023
  • 163 Pages
  • Global
From
Gallbladder Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Gallbladder Cancer Therapeutics Market 2024-2028

  • Report
  • December 2023
  • 166 Pages
  • Global
From
Hypertrophic Cardiomyopathy Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hypertrophic Cardiomyopathy Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 81 Pages
  • Global
From
Cardiovascular Agent Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Cardiovascular Agent Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • October 2024
  • 95 Pages
  • Global
From
Asia Pacific Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Drugs, Type, Route of Administration, and Distribution Channel - Product Thumbnail Image

Asia Pacific Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Drugs, Type, Route of Administration, and Distribution Channel

  • Report
  • February 2023
  • 146 Pages
  • Asia Pacific
From
Europe Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Drugs, Type, Route of Administration, and Distribution Channel - Product Thumbnail Image

Europe Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Drugs, Type, Route of Administration, and Distribution Channel

  • Report
  • February 2023
  • 148 Pages
  • Europe
From
North America Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel - Product Thumbnail Image

North America Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel

  • Report
  • February 2023
  • 143 Pages
  • North America
From
South & Central America Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel - Product Thumbnail Image

South & Central America Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel

  • Report
  • February 2023
  • 128 Pages
From
Middle East & Africa Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel - Product Thumbnail Image

Middle East & Africa Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel

  • Report
  • February 2023
  • 134 Pages
  • Middle East, Africa
From
Loading Indicator